miR-30c Suppresses Prostate Cancer Survival by Targeting the ASF/SF2 Splicing Factor Oncoprotein

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2017.6910
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

The Gene Encoding the Splicing Factor SF2/ASF Is a Proto-Oncogene

Nature Structural and Molecular Biology
Structural BiologyMolecular Biology
2007English

miR‑202 Suppresses Prostate Cancer Growth and Metastasis by Targeting PIK3CA

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Modulation of Exon Skipping and Inclusion by Heterogeneous Nuclear Ribonucleoprotein A1 and Pre-mRNA Splicing Factor SF2/ASF.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1993English

Overexpression of Essential Splicing Factor ASF/SF2 Blocks the Temporal Shift in Adenovirus Pre-mRNA Splicing and Reduces Virus Progeny Formation

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2000English

Human Papillomavirus Type 16 E2 Protein Transcriptionally Activates the Promoter of a Key Cellular Splicing Factor, SF2/ASF

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2008English

Phosphorylation Status of the Kep1 Protein Alters Its Affinity for Its Protein Binding Partner Alternative Splicing Factor ASF/SF2

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2006English

miR-138-5p Suppresses Autophagy in Pancreatic Cancer by Targeting SIRT1

Oncotarget
Oncology
2016English

miR-218 Suppresses Cardiac Myxoma Proliferation by Targeting Myocyte Enhancer Factor 2D

Oncology Reports
MedicineCancer ResearchOncology
2015English

MIR-138-5P Inhibits the Progression of Prostate Cancer by Targeting FOXC1

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy